Determination and control of volatilized 131I released in the preparation of 131I tositumomab dosages for radioimmunotherapy.
Augustine
Samuel C
SC
Nebraska Drug Information Network, University of Nebraska Medical Center, Omaha, NE, USA. saugusti@unmc.edu
Colcher
David M
DM
Rutar
Frank J
FJ
Norenberg
Jeffrey P
JP
Vang
Kao
K
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004339:Drug Compounding / Q000379:methods*; D006207:Half-Life; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; C119496:tositumomab I-131